Maravai Lifesciences Holdings annual operating margin
2019
2020
2021
2022
2023
2024
2025
Maravai Lifesciences Holdings's operating margin was −115.89% for fiscal 2025.
View full Maravai Lifesciences Holdings company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −115.89% | −24.99 pp |
| 2024 | 2024-12-31 | −90.91% | −79.95 pp |
| 2023 | 2023-12-31 | −10.95% | −75.98 pp |
| 2022 | 2022-12-31 | 65.03% | −4.37 pp |
| 2021 | 2021-12-31 | 69.40% | +27.19 pp |
| 2020 · Dec 31 | 2020-12-31 | 42.20% | +25.45 pp |
| 2019 | 2019-12-31 | 16.76% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −29.33% | +110.50 pp |
| Q1 2026 | 2026-03-31 | −3.28% | +101.66 pp |
| Q4 2025 | 2025-12-31 | −117.91% | −51.25 pp |
| Q3 2025 | 2025-09-30 | −98.56% | +141.37 pp |
| Q2 2025 | 2025-06-30 | −139.84% | −120.48 pp |
| Q1 2025 | 2025-03-31 | −104.93% | −75.55 pp |
| Q4 2024 | 2024-12-31 | −66.66% | −57.02 pp |
| Q3 2024 | 2024-09-30 | −239.93% | −216.88 pp |
| Q2 2024 | 2024-06-30 | −19.36% | −2.51 pp |
| Q1 2024 | 2024-03-31 | −29.39% | −32.59 pp |
| Q4 2023 | 2023-12-31 | −9.64% | −63.01 pp |
| Q3 2023 | 2023-09-30 | −23.06% | −84.18 pp |
| Q2 2023 | 2023-06-30 | −16.85% | −91.30 pp |
| Q1 2023 | 2023-03-31 | 3.21% | −65.31 pp |
| Q4 2022 | 2022-12-31 | 53.37% | −14.28 pp |
| Q3 2022 | 2022-09-30 | 61.12% | −14.74 pp |
| Q2 2022 | 2022-06-30 | 74.44% | +3.94 pp |
| Q1 2022 | 2022-03-31 | 68.51% | +6.98 pp |
| Q4 2021 | 2021-12-31 | 67.65% | +35.88 pp |
| Q3 2021 | 2021-09-30 | 75.87% | +23.83 pp |
| Q2 2021 | 2021-06-30 | 70.50% | +53.19 pp |
| Q1 2021 | 2021-03-31 | 61.53% | −6.77 pp |
| Q4 2020 | 2020-12-31 | 31.77% | — |
| Q3 2020 | 2020-09-30 | 52.04% | — |
| Q2 2020 | 2020-06-30 | 17.31% | — |
| Q1 2020 | 2020-03-31 | 68.29% | — |
Over the last five reported fiscal years, Maravai Lifesciences Holdings's operating margin decreased from 42.20% to −115.89%, a change of −158.10 percentage points. The latest reported quarter, Q2 2026, shows −29.33%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Maravai Lifesciences Holdings filings at SEC.gov ↗